TSE:THTheratechnologies Stock Price, Forecast & News

C$2.47

-0.30 (-10.83 %)

(As of 05/29/2020 04:00 PM ET)

Add

Compare

Today's Range

C$2.47

Now: C$2.47▼

C$2.84

50-Day Range

C$2.27

MA: C$2.98▼

C$4.03

52-Week Range

C$1.93

Now: C$2.47▼

C$7.98

Volume1.44 million shs

Average Volume133,358 shs

Market CapitalizationC$190.11 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Theratechnologies Inc., a specialty pharmaceutical company, addresses unmet medical needs to promote healthy living and improve quality of life among HIV patients. It offers EGRIFTA, for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy in Canada and the United States; and Trogarz, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients in the United States. The company was founded in 1993 and is headquartered in Montreal, Canada.

Beat the Market (BTM) Rank^™

3.1 Analyst's Opinion

Consensus Rating
Theratechnologies has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on 1 buy rating, 3 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of C$5.67, Theratechnologies has a potential upside of 129.4% from its current price of C$2.47.
Amount of Analyst Coverage
Theratechnologies has only been the subject of 1 research reports in the past 90 days.

2.4 Community Rank

Outperform Votes
Theratechnologies has received 266 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Theratechnologies has received 296 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Theratechnologies has received 52.67% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Theratechnologies and other stocks. Vote “Outperform” if you believe TH will outperform the S&P 500 over the long term. Vote “Underperform” if you believe TH will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Theratechnologies does not currently pay a dividend.
Dividend Growth
Theratechnologies does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Theratechnologies insiders have sold 24.88% more of their company's stock than they have bought. Specifically, they have bought C$16,136.00 in company stock and sold C$20,150.00 in company stock.

0.0 Earnings and Valuation

Earnings Growth
Earnings for Theratechnologies are expected to decrease by -100.00% in the coming year, from C$0.02 to C$0.00 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Theratechnologies is -12.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Theratechnologies is -12.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Growth Ratio
Due to a projected decrease in earnings for Theratechnologies, their PEG ratio cannot be calculated.
Price to Book Value per Share Ratio
Theratechnologies has a P/B Ratio of 9.18. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

1.11 out of 5 stars

Industry, Sector and Symbol

Stock Exchange TSE

Industry Biotechnology

Sub-IndustryN/A

SectorMedical

Current SymbolTSE:TH

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.theratech.com

Phone+1-514-3367800

Debt

Debt-to-Equity Ratio262.44

Current Ratio2.18

Quick Ratio1.41

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E Ratio123.50

P/E Growth-126.82

Sales & Book Value

Annual SalesC$63.84 million

Price / Sales2.98

Cash FlowC$0.39 per share

Price / Cash Flow6.37

Book ValueC$0.27 per share

Price / Book9.18

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Employees32

Outstanding Shares76,968,000

Market CapC$190.11 million

Next Earnings Date7/9/2020 (Estimated)

OptionableNot Optionable

Receive TH News and Ratings via Email

Sign-up to receive the latest news and ratings for TH and its competitors with MarketBeat's FREE daily newsletter.

Theratechnologies (TSE:TH) Frequently Asked Questions

How has Theratechnologies' stock been impacted by COVID-19 (Coronavirus)?

Theratechnologies' stock was trading at C$3.00 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, TH stock has decreased by 17.7% and is now trading at C$2.47. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Theratechnologies?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Theratechnologies in the last year. There are currently 3 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Theratechnologies.

When is Theratechnologies' next earnings date?

Theratechnologies is scheduled to release its next quarterly earnings announcement on Thursday, July 9th 2020. View our earnings forecast for Theratechnologies.

How were Theratechnologies' earnings last quarter?

Theratechnologies Inc (TSE:TH) posted its quarterly earnings data on Tuesday, April, 14th. The company reported ($0.08) earnings per share for the quarter. The company earned $20.71 million during the quarter, compared to analyst estimates of $24.53 million. View Theratechnologies' earnings history.

What price target have analysts set for TH?

4 brokerages have issued 1 year target prices for Theratechnologies' stock. Their forecasts range from C$4.00 to C$7.00. On average, they anticipate Theratechnologies' share price to reach C$5.67 in the next year. This suggests a possible upside of 129.4% from the stock's current price. View analysts' price targets for Theratechnologies.

Has Theratechnologies been receiving favorable news coverage?

Press coverage about TH stock has trended very negative recently, InfoTrie Sentiment reports. The research firm rates the sentiment of news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Theratechnologies earned a news impact score of -3.8 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 8.0 out of 10, meaning that recent news coverage is very likely to have an effect on the company's share price in the next few days. View the latest news aboutTheratechnologies.

Who are some of Theratechnologies' key competitors?

Some companies that are related to Theratechnologies include Aptose Biosciences (APS), Trillium Therapeutics (TRIL), PureTech Health (PRTC), Bellus Health (BLU), CEL-SCI (CVM), Oxford BioMedica (OXB), Cel-Sci (CVM), SIGA Technologies (SIGA), Paradigm Biopharmaceuticals (PAR), Biotest (BIO), Neptune Wellness Solutions (NEPT), Silence Therapeutics (SLN), TELIX Pharmaceutical (TLX), Starpharma (SPL) and Medicenna Therapeutics (MDNA). View all competitors.

What other stocks do shareholders of Theratechnologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Theratechnologies investors own include Stars Group (TSGI), BCE (BCE), ProMetic Life Sciences (PLI), Theratechnologies (THERF), Teranga Gold (TGZ), Endeavour Mining (EDV), Nemaska Lithium (NMX), Shopify (SHOP), United Therapeutics (UTHR) and Avigilon (AVO).

Who are Theratechnologies' key executives?

Theratechnologies' management team includes the following people:

Mr. Luc Tanguay, Pres, CEO & Non-Independent Director (Age 61)
Mr. Philippe Dubuc MBA, Sr. VP & CFO (Age 52)
Mr. Jocelyn Lafond, VP of Legal Affairs & Corp. Sec. (Age 51)
Mr. Denis Boucher B.A., L.L.B., VP of Communications & Corp. Affairs (Age 53)
Mr. Christian Marsolais, Sr. VP & Chief Medical Officer (Age 56)

What is Theratechnologies' stock symbol?

Theratechnologies trades on the Toronto Stock Exchange (TSX) under the ticker symbol "TH."

How do I buy shares of Theratechnologies?

Shares of TH and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Theratechnologies' stock price today?

One share of TH stock can currently be purchased for approximately C$2.47.

How big of a company is Theratechnologies?

Theratechnologies has a market capitalization of C$190.11 million and generates C$63.84 million in revenue each year. Theratechnologies employs 32 workers across the globe.

What is Theratechnologies' official website?

The official website for Theratechnologies is www.theratech.com.

How can I contact Theratechnologies?

Theratechnologies' mailing address is 2015 Peel St 5th Floor, MONTREAL, QC H3A 1T8, Canada. The company can be reached via phone at +1-514-3367800.

This page was last updated on 5/29/2020 by MarketBeat.com Staff